Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-((2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one MeSH Supplementary Concept Data 2025


MeSH Supplementary
5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-((2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one
Unique ID
C480541
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C480541
Entry Term(s)
PHA 665752
PHA-665752
PHA665752
Registry Numbers
0
Heading Mapped to
*Indoles
*Sulfones
Frequency
93
Note
inhibits c-Met kinase; structure in first source
Source
Cancer Res 2003 Nov 1;63(21):7345-55
Date of Entry
2004/01/14
Revision Date
2004/01/14
5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-((2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one Preferred
PHA 665752 Narrower
page delivered in 0.003s